Now, since both systems agree that a minimum of 20% blasts is required for the diagnosis of AML with BCR::ABL1 to avoid overlap with chronic myeloid leukemia, this entity will not be addressed further in the following discussion. This evidence concerns the gene ABL1 and acute myeloid leukemia.